You have changed your country from  to  . Please be aware that this will change the currency in the purchasing process.

Anti-Cytokeratin 5 antibody [EPR1600Y] (ab75869)

CodeSizePriceAbpointsAvailability
    
 
  • -

  •   
  •   
  •   
  •  

  •  
  •  
  •  

  •  
Updating...

Reassurance, Refunds & Replacements

If your product does not perform as described on this datasheet, we will refund or replace your product...

Read our guarantee »

Overview

Product name

Anti-Cytokeratin 5 antibody [EPR1600Y]
See all Cytokeratin 5 products (15) ...

Description

Rabbit monoclonal [EPR1600Y] to Cytokeratin 5

Tested applications

IHC-Fr, WB, IP, IHC-P, ICCmore details

Cross reactivity

Reacts with

Human

Does not react with

Mouse, Rat

Immunogen

A synthetic peptide corresponding to residues in the head region of human Cytokeratin 5

Positive control

A431 cell lysate and human squamous cervical carcinoma tissue.

General notes

Produced under U.S. Patent No. 5,675,063.

Properties

Form

Liquid

Storage instructions

Store at -20°C. Stable for 12 months at -20°C

Storage buffer

PBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%

Purity

Tissue culture supernatant

Clonality

Monoclonal

Clone number

EPR1600Y

Isotype

IgG

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 5 antibody [EPR1600Y] (ab75869)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 5 antibody [EPR1600Y] (ab75869) image (enlarge)

  • Western blot - Cytokeratin 5 antibody [EPR1600Y] (ab75869)Western blot - Cytokeratin 5 antibody [EPR1600Y] (ab75869) image (enlarge)

  • Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Anti-Cytokeratin 5 antibody [EPR1600Y](ab75869)Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Anti-Cytokeratin 5 antibody [EPR1600Y](ab75869) image (enlarge)

Applications

Show applications key

Our Abpromise guarantee covers the use of ab75869 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application notes

ICC: 1/250 - 1/500.
IHC-P: 1/100 - 1/250. Perform heat mediated antigen retrieval before commencing with IHC staining protocol.
IHC-Fr: Use at an assay dependent dilution (PMID 19949112).
IP: 1/60.
WB: 1/10,000 - 1/20,000. Detects a band of approximately 62 kDa (predicted molecular weight: 62 kDa).

Is unsuitable for Flow Cyt.


Not yet tested in other applications.
Optimal dilutions/concentrations should be determined by the end user.

Target

Involvement in disease

Defects in KRT5 are a cause of epidermolysis bullosa simplex Dowling-Meara type (DM-EBS) [MIM:131760]. DM-EBS is a severe form of intraepidermal epidermolysis bullosa characterized by generalized herpetiform blistering, milia formation, dystrophic nails, and mucous membrane involvement.
Defects in KRT5 are the cause of epidermolysis bullosa simplex with migratory circinate erythema (EBSMCE) [MIM:609352]. EBSMCE is a form of intraepidermal epidermolysis bullosa characterized by unusual migratory circinate erythema. Skin lesions appear from birth primarily on the hands, feet, and legs but spare nails, ocular epithelia and mucosae. Lesions heal with brown pigmentation but no scarring. Electron microscopy findings are distinct from those seen in the DM-EBS, with no evidence of tonofilament clumping.
Defects in KRT5 are a cause of epidermolysis bullosa simplex Weber-Cockayne type (WC-EBS) [MIM:131800]. WC-EBS is a form of intraepidermal epidermolysis bullosa characterized by blistering limited to palmar and plantar areas of the skin.
Defects in KRT5 are a cause of epidermolysis bullosa simplex Koebner type (K-EBS) [MIM:131900]. K-EBS is a form of intraepidermal epidermolysis bullosa characterized by generalized skin blistering. The phenotype is not fundamentally distinct from the Dowling-Meara type, althought it is less severe.
Defects in KRT5 are the cause of epidermolysis bullosa simplex with mottled pigmentation (MP-EBS) [MIM:131960]. MP-EBS is a form of intraepidermal epidermolysis bullosa characterized by blistering at acral sites and 'mottled' pigmentation of the trunk and proximal extremities with hyper- and hypopigmentation macules.
Defects in KRT5 are the cause of Dowling-Degos disease (DDD) [MIM:179850]; also known as Dowling-Degos-Kitamura disease or reticulate acropigmentation of Kitamura. DDD is an autosomal dominant genodermatosis. Affected individuals develop a postpubertal reticulate hyperpigmentation that is progressive and disfiguring, and small hyperkeratotic dark brown papules that affect mainly the flexures and great skin folds. Patients usually show no abnormalities of the hair or nails.

Sequence similarities

Belongs to the intermediate filament family.

Target information above from: UniProt accessionP13647 The UniProt Consortium
The Universal Protein Resource (UniProt) in 2010
Nucleic Acids Res. 38:D142-D148 (2010).

Information by UniProt

Alternative names

  • type II cytoskeletal 5 antibody
  • 58 kDa cytokeratin antibody
  • CK 5 antibody
  • CK-5 antibody
  • CK5 antibody
  • Cytokeratin-5 antibody
  • Cytokeratin5 antibody
  • DDD antibody
  • EBS 2 antibody
  • EBS2 antibody
  • epidermolysis bullosa simplex 2 Dowling-Meara/Kobner/Weber-Cockayne types antibody
  • K2C5_HUMAN antibody
  • K5 antibody
  • Keratin 5 (epidermolysis bullosa simplex Dowling Meara/Kobner/Weber Cockayne types) antibody
  • keratin 5 (epidermolysis bullosa simplex, Dowling-Meara/Kobner/Weber-Cockayne types) antibody
  • Keratin 5 antibody
  • Keratin antibody
  • keratin complex 2, basic, gene 5 antibody
  • Keratin Type II Cytoskeletal 5 antibody
  • keratin, type II cytoskeletal 5 antibody
  • Keratin-5 antibody
  • Keratin5 antibody
  • KRT 5 antibody
  • KRT 5A antibody
  • KRT5 antibody
  • KRT5A antibody
  • Type-II keratin Kb5 antibody
see all

Anti-Cytokeratin 5 antibody [EPR1600Y] images:

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 5 antibody [EPR1600Y] (ab75869)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Cytokeratin 5 antibody [EPR1600Y] (ab75869)

ab75869 at 1/100 dilution staining Cytokeratin 5 in human squamous cervical carcinoma by Immunohistochemistry, Paraffin-embedded tissue.

  Western blot - Cytokeratin 5 antibody [EPR1600Y] (ab75869)

Western blot - Cytokeratin 5 antibody [EPR1600Y] (ab75869)

Anti-Cytokeratin 5 antibody [EPR1600Y] (ab75869) at 1/10000 dilution + A431 cell lysate at 10 µg

Secondary
goat anti-rabbit HRP at 1/2000 dilution

Predicted band size : 62 kDa
Observed band size : 62 kDa

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Anti-Cytokeratin 5 antibody [EPR1600Y](ab75869)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Anti-Cytokeratin 5 antibody [EPR1600Y](ab75869)

Fluorescent immunohistochemical analysis of paraffin-embedded human cervical carcinoma tissue using ab75869. Green-CK5 red-PI

  Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Anti-Cytokeratin 5 antibody [EPR1600Y](ab75869)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)-Anti-Cytokeratin 5 antibody [EPR1600Y](ab75869)

Fluorescent immunohistochemical analysis of paraffin-embedded human cervical carcinoma using ab75869. Green-CK5 red-PI.

References for Anti-Cytokeratin 5 antibody [EPR1600Y] (ab75869)

This product has been referenced in:

  • Nobrega C  et al. Dissemination of mycobacteria to the thymus renders newly generated T cells tolerant to the invading pathogen. J Immunol 184:351-8 (2010). IHC-Fr; Mouse.Read more (PubMed: 19949112) »

See 1 publication for this product

Publishing research using ab75869? Please let us know so that we can cite the reference in this datasheet

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"